Alan F. Denenberg
Lawyers
Filters
Marathon Digital Holdings $300 million convertible notes offering
The 2.125% convertible notes are due 2031
Penumbra $100 million accelerated share repurchase
We advised Penumbra on the ASR transaction
Alkami Technology $155.9 million secondary offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $58.3 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $500 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SGH $175 million convertible notes offering and capped call transactions
The 2% convertible senior notes are due 2030
Netflix $1.8 billion senior notes offering
The investment-grade notes were issued in two tranches
IDEAYA Biosciences $302.5 million equity offering
The common stock is listed on the Nasdaq Global Select Market
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Nokia $2.3 billion acquisition of Infinera
We are advising Centerview Partners as financial adviser to Infinera